Less than $1M later, Washington device startup eyes FDA submission

Talk about an affordable medical device. Cardiac Insight in Washington state is gearing up to seek FDA clearance by year-end for a product designed to monitor patients for atrial fibrillation. And the company, spun out of the University of Washington, used less than $1 million of investor cash to get there, Xconomy reports. If all goes well, the device should hit the market by mid-2013, according to the article. It weighs about a quarter-of-an-ounce and has a flexible circuit board so it can be worn easily. What's more, it's also cheap to produce, at less than $25 per device, the story explains. To boost its chances for success, Cardiac Insight just named co-founder and entrepreneur Brad Harlow as its new acting CEO, who will focus on eventually selling the company. Story

Suggested Articles

The randomized, blinded study showed statistically significant improvements in assessments of inattention and brain activity.

U.K.-based surgery robot developer CMR Surgical has begun rolling out its Versius platform to the NHS, completing its first procedures in Europe.

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.